{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-JDY0HG2P/b60c4e31-476c-4427-af24-cec6bfe0a732/PDF","dcterms:extent":"99 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-JDY0HG2P/99fe7ea6-12ab-4723-9379-46ed2b7d66db/TEXT","dcterms:extent":"20 KB"}],"edm:TimeSpan":{"@rdf:about":"1929-2026","edm:begin":{"@xml:lang":"en","#text":"1929"},"edm:end":{"@xml:lang":"en","#text":"2026"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:doc-JDY0HG2P","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp"},{"@xml:lang":"sl","#text":"Zdravniški vestnik"}],"dcterms:issued":"2014","dc:creator":["Horvat-Ledinek, Alenka","Rot, Uroš","Šega, Saša"],"dc:format":[{"@xml:lang":"sl","#text":"številka:7/8"},{"@xml:lang":"sl","#text":"letnik:83"},{"@xml:lang":"sl","#text":"str. 538-543"}],"dc:identifier":["ISSN:1318-0347","COBISSID:1700012","URN:URN:NBN:SI:doc-JDY0HG2P"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Slovensko zdravniško društvo"},"dc:subject":[{"@xml:lang":"sl","#text":"ekonomsko breme"},{"@xml:lang":"sl","#text":"imunomodulatorna terapija"},{"@xml:lang":"sl","#text":"multipla skleroza"},{"@xml:lang":"sl","#text":"napredovanje bolezni"},{"@xml:lang":"sl","#text":"zagon"}],"dcterms:temporal":{"@rdf:resource":"1929-2026"},"dc:title":{"@xml:lang":"sl","#text":"Ekonomsko breme multiple skleroze| The economic burden of multiple sclerosis|"},"dc:description":{"@xml:lang":"sl","#text":"Multipla skleroza (MS) je kronična, vnetna bolezen osrednjega živčevja, ki močno vpliva na kakovost življenja. Prizadene mlade ljudi in je najpogostejši vzrok invalidnosti v zgodnjem življenjskem obdobju. Ekonomsko breme MS je visoko. V zgodnjem obdobju so najpomembnejši generator stroškov sodobna imunomodulatorna zdravila, pri bolnikih s hujšo prizadetostjo pa so v ospredju stroški nege in zdravljenja simptomov ter posredni stroški zaradi zgodnjega upokojevanja. Stroški MS naraščajo s stopnjo prizadetosti zaradi bolezni, zato ima zgodnje zdravljenje in razvoj zdravil, ki vplivajo na napredovanje bolezni ugoden ekonomski vpliv na posameznika in celotno družbo"},"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:doc-JDY0HG2P","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:doc-JDY0HG2P"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:doc-JDY0HG2P/b60c4e31-476c-4427-af24-cec6bfe0a732/PDF"},"edm:rights":{"@rdf:resource":"http://creativecommons.org/licenses/by-nc/4.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Slovensko zdravniško društvo"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:doc-JDY0HG2P/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:doc-JDY0HG2P"}}}}